Northeastern State University Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2015
NCT02472223
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Thomas O Salmon, OD, PhD